Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2026 · 10-Q
Revenue$214.54K$214.54K+59.0% vs Q1 2025 Net Income-$831.23K-$831.23KN/M vs Q1 2025 EPS Diluted-$0.03-$0.03N/M vs Q1 2025 Operating Income-$956,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Margins · derivedOperating margin-445.6%+249.7 pt vs Q1 2025
Net margin-387.4%+236.3 pt vs Q1 2025
ended Mar 31, 2026 · filed May 15, 2026 · 45 d after period end